QNTM

MRSH

Financialslarge cap
QNTM SCORE
56/100
MODERATE CONVICTION
top 18% of the universe

As of 2026-09-10, MRSH scores 56out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. MRSH trades at $177.29, 25% above the band ceiling.

MRSH scores 56 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 56. Its strongest factor is value at 83 (exceptional), where it screens cheap on the model's valuation inputs, followed by sentiment at 66. The weakest is momentum at 41, where price trend is the soft spot. Among Financials stocks it ranks in roughly the top 18% of the Financials names the model scores.

On valuation, MRSH is priced near the top of its recent range — the rich end on the model's valuation read. The blended composite before the macro overlay was 55. Same-sector names the model rates nearby include OSCR, MRX, VCTR.

This is a descriptive factor read on MRSH, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where MRSH sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

Momentum41
Quality50
Value83
Volume45
Sentiment66

VALUATION RANGE

QNTM’s descriptive fair-value band for MRSH runs $107.31–$141.66. Current price $177.29 sits 25% above the band ceiling. This is valuation context, not a price target.

MRSH APPEARS IN

Top Value
See MRSH update live, and set an alert when its conviction changes

QNTM rescores MRSH and ~1,400 other names every session. Track it, get notified the moment it crosses a conviction tier, and see the full signal history.

Start free →

OTHER FINANCIALS NAMES

OSCR70MRX69VCTR68LNC68ESNT67XP67PLMR67NMIH67

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.